OBJECTIVE: To study the relationship of anaphylatoxin @entity4417 level in @entity1069 ( @entity1069 ) with prostate tissue @entity32 in BPH. METHODS: This study included 40 BPH @entity1 receiving TURP operational therapy in West China Hospital during September, 2009 to March, 2010. For each @entity1 , IPSS and NIH-CPSI were evaluated, serum PSA levels, prostatic volume and urine WBC were measured. @entity1069 was collected before operation for the test of @entity4417 level, while @entity1069 also was obtained from 10 healthy @entity1 as normal control. Prostatic tissue was collected by the operation and histological @entity32 was investigated by histopathological study. RESULTS: @entity4417 levels in @entity1069 of the BPH @entity1 : severe @entity32 group > mild @entity32 group > normal control group (all P < 0.01). @entity4417 levels in the @entity1069 could be used to determine whether BPH combined @entity32 , sensitivity : 0.97, specificity: 0.70. @entity4417 levels in @entity1069 was not relevant with PSA, fPSA levels, age, BMI, prostate volume or urine WBC levels; but NIH-CPSI was correlated (r = 0.495, P < 0.01). @entity4417 in @entity1069 of retained catheter group was more than non-catheter group significantly (P < 0.05). CONCLUSION: @entity4417 is an ideal criteria to diagnose prostatic histological @entity32 in BPH @entity1 . There is no convincing evidence to correlate @entity4417 in @entity1069 with serum PSA levels, BMI, age, prostatic volume and urine's WBC. Excessively high @entity4417 levels and the NIH-CPSI, indwelling have correlations.

[The relationship between anaphylatoxin @entity4417 and benign prostatic hyperplasia with XXXX ].

@entity1069 :: ('MESH:D053448', 'Disease') :: ['expressed prostatic secretions', 'EPS'] @entity32 :: ('MESH:D007249', 'Disease') :: ['inflammation'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'men'] @entity4417 :: ('718', 'Gene') :: ['C3a']
@entity32 :: (MESH:D007249,Disease) :: ['inflammation']
